Inactive Instrument

Insiders RXi Pharmaceuticals Corp Nasdaq

Equities

US74979C3034

End-of-day quote Nasdaq Other stock markets
- ^USD	-

Apr. 22	Phio Pharmaceuticals Corp. Presents New Data About Its Lead Clinical Product Candidate, PH-762	CI
Apr. 16	Phio Pharmaceuticals Announces Upcoming Presentations at the 81st Annual Meeting of the Society for Investigative Dermatology	CI

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Phio Pharmaceuticals Corp. Appoints Robert Bitterman as President	23-02-22	CI
Phio Pharmaceuticals Corp. Appoints Robert Bitterman as Chief Executive Officer	23-02-22	CI
Phio Pharmaceuticals Corp. Announces Board Appointments	22-09-29	CI
Phio Pharmaceuticals Corp. Announces Management Changes	22-05-05	CI
Phio Pharmaceuticals Corp. Announces Departure of Gerrit Dispersyn as Chief Executive Officer	22-05-05	CI
Phio Pharmaceuticals Corp. Announces the Appointment of Patricia A. Bradford to Its Board of Directors	22-05-02	CI
Phio Pharmaceuticals Corp. Approves Appointment of Robert L. Ferrara as Director	19-10-25	CI
Keith L. Brownlie Not Stands for Re-Election at the 2019 Annual Meeting of Phio Pharmaceuticals Corp	19-08-30	CI
Phio Pharmaceuticals Corp. Announces Management Changes, Effective March 1, 2019	19-02-15	CI
RXi Pharmaceuticals Corporation has Changed its Name to Phio Pharmaceuticals Corp	18-11-19	CI
RXi Pharmaceuticals Corporation Appoints Gerrit Dispersyn as President and Chief Operating Officer	18-11-14	CI
RXi Pharmaceuticals Announces the Departure of Dr. Alexey Eliseev as Chief Business Officer	17-09-15	CI
RXi Pharmaceuticals Corporation Appoints Jonathan Freeman to its Board of Directors	17-06-07	CI
RXi Pharmaceuticals Announces Management Changes	17-04-18	CI
RXi Pharmaceuticals Corporation Appoints Dr. James Griffin to Scientific Advisory Board	17-02-14	CI
RXi Pharmaceuticals Corporation Appoints Rolf Kiessling to its Scientific Advisory Board	17-02-07	CI
RXi Pharmaceuticals Corporation Appoints Alexey Eliseev as Chief Business Officer	17-01-09	CI
RXi Pharmaceuticals Appoints Peter Campochiaro to Scientific Advisory Board	14-07-07	CI
RXi Pharmaceuticals Corporation Announces Board Appointments	13-04-22	CI
RXi Pharmaceuticals Corporation Announces Board Appointments	12-07-13	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Insiders RXi Pharmaceuticals Corp Nasdaq

Equities

US74979C3034

Insiders

Filters